St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor
Top Cited Papers
- 13 June 2000
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 97 (13) , 7500-7502
- https://doi.org/10.1073/pnas.130155097
Abstract
St. John's wort ( Hypericum perforatum ) is an herbal remedy used widely for the treatment of depression. Recent clinical studies demonstrate that hypericum extracts increase the metabolism of various drugs, including combined oral contraceptives, cyclosporin, and indinavir. In this report, we show that hyperforin, a constituent of St. John's wort with antidepressant activity, is a potent ligand ( K i = 27 nM) for the pregnane X receptor, an orphan nuclear receptor that regulates expression of the cytochrome P450 (CYP) 3A4 monooxygenase. Treatment of primary human hepatocytes with hypericum extracts or hyperforin results in a marked induction of CYP3A4 expression. Because CYP3A4 is involved in the oxidative metabolism of >50% of all drugs, our findings provide a molecular mechanism for the interaction of St. John's wort with drugs and suggest that hypericum extracts are likely to interact with many more drugs than previously had been realized.Keywords
This publication has 22 references indexed in Scilit:
- Herb-drug interactionsPublished by Elsevier ,2000
- The Pregnane X Receptor: A Promiscuous Xenobiotic Receptor That Has Diverged during EvolutionMolecular Endocrinology, 2000
- SXR, a novel steroid and xenobioticsensing nuclear receptorGenes & Development, 1998
- The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions.Journal of Clinical Investigation, 1998
- St. John's Wort in Mild to Moderate Depression: The Relevance of Hyperforin for the Clinical EfficacyPharmacopsychiatry, 1998
- Oral Bioavailability of Hyperforin from Hypericum Extracts in Rats and Human VolunteersPharmacopsychiatry, 1998
- Activity Profiles of Two Hyperforin-Containing Hypericum Extracts in Behavioral ModelsPharmacopsychiatry, 1998
- Hyperforin Represents the Neurotransmitter Reuptake Inhibiting Constituent of Hypericum ExtractPharmacopsychiatry, 1998
- LI 160, an Extract of St. John's Wort, Versus Amitriptyline in Mildly to Moderately Depressed Outpatients - A Controlled 6-Week Clinical TrialPharmacopsychiatry, 1997
- Controlled Clinical Trials of Hypericum Extracts in Depressed Patients - an OverviewPharmacopsychiatry, 1997